Registration for the much-anticipated 2021 PKD Regulatory Summit (May 19-20) is now open!
Together with key stakeholders from the pharmaceutical industry, academic researchers, foundations, patient advocacy groups, individuals living with PKD, and regulatory agencies from around the world, we will address current unmet drug development needs for PKD, identify tools that are needed to deliver new therapies to patients, and catalyze the development of a regulatory framework to enable advancement of new treatments.
For more information on the registration and agenda please visit the official event website,
